Nearly half of all adults with type 2 diabetes mellitus (T2DM) live in India and China. These
populations have an underlying predisposition to deficient insulin secretion, which has a key …

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a well-established class of
glucose-lowering drugs. GLP-1 RAs can be classified according to their structure, duration of …

Aim Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA)
indicated for glycaemic management in adults with type 2 diabetes (T2D). Oral semaglutide …

The prevalence of obesity continues to grow rapidly worldwide, posing many public health
challenges of the 21st century. Obese subjects are at major risk for serious diet-related …

There are no effective targeted therapies to treat acute respiratory distress syndrome
(ARDS). Recently, the commonly used diabetes and obesity medications, glucagon-like …

Bone cells express the glucagon-like peptide 1 receptor (GLP-1R). However, its presence
and role in human dental pulp derived stem cells (hDPSCs) remains elusive. Hence, in the …

Approximately 14.4 million Americans are experiencing alcohol use disorder (AUD) and
about two-thirds of people who experience drug addiction will relapse, highlighting the need …

It is a well-accepted fact that obesity and diabetes increase the risk of incidence of different
cancers and their progression, leading to a decrease in the quality of life among affected …

Abstract Objective To evaluate the Safety and Efficacy of Hydroxychloroquine as add-on
therapy in uncontrolled type 2 diabetes patients who were using two oral antidiabetic drugs …

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have gained an important place in
the management of diabetes management because of their exceptional glucose-lowering …